Post-Surgery Circulating Tumor Cells and AXL Overexpression as New Poor Prognostic Biomarkers in Resected Lung Adenocarcinoma

Artículo original

Año: 2019

de Miguel-Perez, D; Bayarri-Lara, CI; Ortega, FG; Russo, A; Rodriguez, MJM; Alvarez-Cubero, MJ; Serrano, EM; Lorente, JA; Rolfo, C; Serrano, MJ

Título: CANCERS

• Q1